| 179 | 0 | 97 |
| 下载次数 | 被引频次 | 阅读次数 |
建立高效液相色谱法(HPLC-DAD)同时检测布美他尼原料药中的8种杂质含量。采用Thermo Hypersil GOLD C18(4.6 mm×250 mm, 5μm,孔径120?)为色谱柱,以0.1%(体积分数)三氟乙酸溶液(取1 mL三氟乙酸溶于1 000 mL水中)为流动相A,甲醇为流动相B,梯度洗脱(0~5 min 60%A;5~10 min 60%A→15%A;10~20 min 15%A;20~25 min 15%A→60%A;25~30 min 60%A),流速为1.0 mL/min,柱温为30℃,进样量为20μL。空白溶剂不干扰布美他尼及其8种杂质的测定,杂质A、B、C、D、E、G、I、J质量浓度分别在0.020 1~4.028 0、0.028 0~3.730 1、0.045 8~3.661 8、0.050 9~4.069 2、0.048 5~3.877 3、0.101 1~4.042 8、0.050 9~4.070 0和0.051 8~4.147 7μg/mL范围内与相应峰面积呈良好的线性关系,相关系数r分别为0.999 3、0.999 1、0.999 9、0.999 4、0.999 6、0.999 2、0.999 9、0.998 8,检测限(LOD)为7.05~35.37 ng/mL,定量限(LOQ)为20.14~101.07 ng/mL,杂质A、B、C、D、E、G、I、J的平均回收率分别为95.4%、93.0%、101.1%、98.7%、100.0%、101.0%、101.2%、98.1%,RSD分别为1.26%、0.63%、1.97%、0.40%、3.08%、0.79%、1.18%、0.85%。所建立的高效液相色谱法(HPLC)高效、稳健、准确,可同时测定布美他尼原料药中8种杂质(工艺杂质与降解产物)的含量。
Abstract:A high-performance liquid chromatography method with diode-array detection(HPLC-DAD) was established for the simultaneous determination of eight impurities in bumetanide active pharmaceutical ingredient(API).A Thermo Hypersil GOLD C18(4.6 mm×250 mm, 5 μ m, pore size120 ?) was used, with 0.1% volume fraction trifluoroacetic acid solution(prepared by dissolving 1 mL trifluoroacetic acid in 1 000 mL water) as mobile phase A and methanol as mobile phase B.A gradient elution was employed(0~5 min 60% A;5~10 min 60% A→15% A;10~20 min 15% A;20~25 min 15% A→60% A;25~30 min 60% A).The flow rate was 1.0 mL/min, the column temperature was 30 ℃,and the injection volume was 20 μL.The blank solvent showed no interference with the detection of bumetanide or its eight impurities.The mass concentrations of impurities A,B,C,D,E,G,I,and J showed good linear relationships with their corresponding peak areas in the range of 0.020 1~4.028 0,0.028 0~3.730 1,0.045 8~3.661 8,0.050 9~4.069 2,0.048 5~3.877 3,0.101 1~4.042 8,0.050 9~4.070 0,and 0.051 8~4.147 7 μg/mL,respectively.The correlation coefficients r was 0.999 3,0.999 1,0.999 9,0.999 4,0.999 6,0.999 2,0.999 9,and 0.998 8.The limits of detection(LOD) ranged from 7.05 to 35.37 ng/mL,and the limits of quantification(LOQ) ranged from 20.14 to 101.07 ng/mL.The average recoveries of impurities A,B,C,D,E,G,I,and J were 95.4%,93.0%,101.1%,98.7%,100.0%,101.0%,101.2%,and 98.1%,respectively, with corresponding relative standard deviations(RSDs) of 1.26%,0.63%,1.97%,0.40%,3.08%,0.79%,1.18%,and 0.85%.The established HPLC method is efficient, robust and accurate, and is suitable for the simultaneous determination of eight impurities(both process-related impurities and degradation products) in bumetanide API.
[1]L?scher W,Gramer M,R?mermann K.Biopharm.Drug Dispos.,2024,45(3):138-148.
[2]Ge Y Q,Ye X X,Le J,Yang Y J,Wang Y.J.Pharm.Anal.,2020,40(1):83-89.葛雨琦,叶晓霞,乐健,杨永健,王彦.药物分析杂志,2020,40(1):83-89.
[3]Schlingemann J,Burns M J,Ponting D J,Avila C M,Romero N E,Jaywant M A,Smith G F,Ashworth I W,Simon S,Saal C,Wilk A.J.Pharm.Sci.,2022,112(5):1 287-1 304.
[4]Shakleya D,Asmelash B,Alayoubi A,Abrigo N,Mohammad A,Wang J,Zhang J H,Yang J Y,Marzan T A,Li D,Shaklah M,Alsharif F M,Desai S,Faustino P J,Ashraf M,O′connor T,Vera M,Raw A,Sayeed V A,Keire D.J.Pharm.Sci.,2023,112(12):3 075-3 087.
[5]Wen H R,Huang Q,Han S Q,Jiang H,Qin C,Shi H K,Zhao T T,Geng X C,Wang Q.Chin.J.Pharm.,2024,21(3):307-312;318.文海若,黄勤,韩素芹,姜华,秦超,石皓琨,赵婷婷,耿兴超,汪祺.中国药物警戒,2024,21(3):307-312;318.
[6]Tian Y,Tao X S,Feng Y Y,Yao S C,Yin L H,Ning B M.Chin.J.Antibiot.,2024,49(1):13-25.田冶,陶晓莎,冯媛媛,姚尚辰,尹利辉,宁保明.中国抗生素杂志,2024,49(1):13-25.
[7]Peng S Y,Chen H,Yin J.Drug Eval.Res.,2022,45(12):2 583-2 590.彭诗雁,陈华,尹婕.药物评价研究,2022,45(12):2 583-2 590.
[8]Wan J Y,Chen H,Yin J.J.Pharm.Anal.,2022,42(4):557-571.万君玥,陈华,尹婕.药物分析杂志,2022,42(4):557-571.
[9]The United States Pharmacopeial Convention.United States Pharmacopeia-National Formulary 43rd Edition,Rockwell:The US Food and Drug Administration,2019.
[10]Chinese Pharmacopoeia Commission.Pharmacopoeia of the People′s Republic of China(2020 edition).2020 Edition Part 2 and Part 4.Beijing:China Medical Science and Technology Press,2020.国家药典委员会.中华人民共和国药典(2020年版),2020年版二部和四部.北京:中国医药科技出版社,2020.
[11]European Pharmacopoeia Committee.European Pharmacopoeia.EP11.0.Strasbourg:European Directorate for the Quality of Medicines & Health Care,2023.欧洲药典委员会.欧洲药典.EP11.0.斯特拉斯堡:欧洲药品质量管理局,2023.
[12]ICHQ3A(R2).Impurities in New Active Pharmaceutical Ingredients,2006-10-25.
[13]Zhao S J,Qu M M,Wang C X,Gong Y,Xu H,Liu C C,Xie J W.Chin.J.Pharmacol.Toxicol.,2023,37(3):229-240.赵舒婧,瞿敏敏,王朝霞,龚莹,徐华,刘翠翠,谢剑炜.中国药理学与毒理学杂志,2023,37(3):229-240.
[14]Liu N,Gu H,Li X,She C,Min Y H,Li S C.Phy.Test.Chem.Anal.B:Chem.Anal.,2023,59(8):930-936.刘娜,辜慧,李旭,佘城,闵宇航,李澍才.理化检验-化学分册,2023,59(8):930-936.
[15]Pan C,Meng P,Xu D M,Huang S L,Huang Y H,Cai X M,Chen N J.Chin.J.Anal.Lab.,2024,43(12):1 778-1 784.潘城,孟鹏,徐敦明,黄姝玲,黄永辉,蔡小明,陈宁静.分析试验室,2024,43(12):1 778-1 784.
[16]Wang R Y,Si F F,Chen Q J,Ren Y P.Phy.Test.Chem.Anal.B:Chem.Anal.,2023,59(8):948-952.王荣艳,斯菲菲,陈青俊,任一平.理化检验-化学分册,2023,59(8):948-952.
基本信息:
DOI:10.13822/j.cnki.hxsj.2025.0053
中图分类号:O657.72;TQ460.72
引用信息:
[1]叶红兵,张蒙蒙,夏宇航,等.高效液相色谱法同时测定布美他尼原料药中8种杂质含量[J].化学试剂,2025,47(08):73-80.DOI:10.13822/j.cnki.hxsj.2025.0053.
2025-03-19
2025
2025-05-14
2025
1
2025-08-15
2025-08-15